摘要
目的 观察莫沙必利治疗反流性食管炎的疗效及安全性。方法 治疗组 60例患者于 3餐前及睡前 2 0～ 3 0min口服莫沙必利 5～ 10mg ,4周为 1疗程 ,并与服用胃复安的对照组相比较。结果 莫沙必利可有效控制反流性食管炎的各种症状 ,使食管滴酸试验转阴、X线钡透胃食管反流消失 ,且无明显毒副作用。与胃复安疗效比较差异非常显著 (P <0 0 1)。结论 莫沙必利治疗反流性食管炎疗效显著且安全可靠 ,值得推广应用。
To observe the curative effect and safety of mosapride in treating reflux Esophagitis. 60 patients of the case group were treated with mosapride for 28 days, 3 times a day before meal and sleep with a dose of 5~10 mg orally, the result was compared with that of the control group treated with metoclopramide. Mosapride could effectively control various symptoms of reflux esophagitis with no obvious side effects. The difference was significant compared with the control group(P<0.01). [Conclusion] Mosapride is effective and reliable in treating reflux esophagitis.
出处
《职业与健康》
CAS
2005年第3期456-457,共2页
Occupation and Health
